Inhibitory Potential of Shen-Shuai-Ling Formulation on Renal Interstitial Fibrosis via Upregulation of PLZF

• Published in: Evidence-based complementary and alternative medicine 2022, Vol.2022, p.5967804-9
• Main Authors: Song, Na, Tu, Haitao, Li, Ying, Xiong, Weijian, Zhang, Ling, Liu, Hong, Ding, Weisen, Long, Mei, Ren, Dewei, Zhong, Jin
• Format: Article
• Language: English
• Subjects: Angiotensin; Antigens; Chinese medicine; Experiments; Fibrosis; Gene expression; Kidney diseases; Kidneys; Ligands; Medical research; Promyeloid leukemia; Proteins; Renin; Traditional Chinese medicine; Transcription factors; Transforming growth factor-b; Up-regulation; Zinc finger proteins
• ISSN: 1741-427X; 1741-4288
• DOI: 10.1155/2022/5967804

Background. Renal interstitial fibrosis (RIF) is an important cause of kidney disease, which seriously affects people’s health. As a traditional Chinese medicine, Shen-Shuai-Ling Formulation (SSLF) has obvious kidney function. However, the therapeutic effect of SSLF on RIF and its molecular mechanism are still unclear. Methods. First, the potential targets and pathways of SSLF for RIF were predicted by network pharmacology, and then, the binding of luteolin and target protein to SSLF was verified by molecular docking and Co-IP experiments. Finally, the effects of SSLF and luteolin on PLZF and (Pro) renin receptor (PRR) were verified by western blot and qPCR experiments. Angiotensin (Ang)-1, Ang-2, and transforming growth factor-β (TGF-β) were the indexes of renal interstitial fibrosis. Results. Through the drug-active component-target network diagram, we found that luteolin has the most connections, and promyelocytic leukemia zinc finger (PLZF) is the target protein. GO analysis and KEGG pathway analysis of targets were performed using Cytoscape ClueGO. Molecular docking experiments and Co-IP are used to prove that luteolin and PLZF can be combined. Western blot and qPCR results showed that both SSLF and luteolin significantly upregulated the expression of PLZF and decreased the levels of PRR, Ang-1, Ang-2, and TGF-β. The overexpression of PLZF decreased the expression of PRR, the knockdown of PLZF increased the expression of PRR, and the overexpression of PRR decreased the expression of Ang-1, Ang-2, and TGF-β. Conclusions. SSLF inhibits PRR and renal interstitial fibers by the upregulation of PLZF levels.